1 Min Read
Feb 2 (Reuters) - Teva Pharmaceutical Industries Ltd :
* EUROPEAN MEDICINES AGENCY (EMA) ACCEPTS FREMANEZUMAB MARKETING AUTHORIZATION APPLICATION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.